Sort
11,323 grants matching “glioblastoma”
Verteporfin as a YAP/TAZ inhibitor for treatment of glioblastoma
$560,145Renee D Read · Emory University · R01 · FY2024 · NS
Pre-Clinical Trials of GEM Models for Gliomas
$560,077Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · CA
Predicting brain tumor progression via multiparametric image analysis and modelin
$560,015Christos Davatzikos · University Of Pennsylvania · R01 · FY2014 · NS
Development of Quantitative Deuterium MRS Imaging for Human Brain Tumor Application at Ultrahigh Field
$559,810Wei Chen · University Of Minnesota · R01 · FY2020 · CA
Image-based models of tumor-immune dynamics in glioblastoma
$559,690Leland Hu · Mayo Clinic Arizona · U01 · FY2025 · CA
Project 1: Design Rules for Spherical Nucleic Acids that Target Cancer
$559,505Milan Mrksich · Northwestern University At Chicago · U54 · FY2019 · CA
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
$559,312James M Markert · University Of Alabama At Birmingham · R01 · FY2018 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$559,275William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
Determining the role of lipid droplets and their therapeutic potential in glioblastoma
$558,620Deliang Guo · Ohio State University · R01 · FY2023 · NS
Manipulating normal estrogen physiology as a therapeutic approach in cancer
$558,602Donald P McDonnell · Duke University · R01 · FY2023 · CA
Cell State Network-Directed Therapy
$558,333Marc R. Birtwistle · Clemson University · U01 · FY2024 · CA
Clinical Development of Rhenium Nanoliposomes (RNL186) for Glioblastoma
$558,207Andrew Jacob Brenner · University Of Texas Hlth Science Center · R01 · FY2022 · CA
Angiogenesis imaging
$558,093Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Deciphering heritability, plasticity and differentiation trajectories in gliomas via single-cell multi-omics
$558,064Mario Luca Suva · Massachusetts General Hospital · R01 · FY2025 · CA
A RIPK2-Targeting Apoptosis-Inducing Small Molecule for the Treatment of Glioblastoma
$557,933Luke Lee Lairson · Scripps Research Institute, The · R01 · FY2019 · NS
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
$557,887Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2016 · CA
Pre-Clinical Trials of GEM Models for Gliomas
$557,604Eric C Holland · Sloan-Kettering Inst Can Research · R01 · FY2006 · CA
Temporal analysis of the GBM tumor microenvironment during myeloid cell activating therapy
$557,266Ralph Weissleder · Massachusetts General Hospital · R01 · FY2024 · CA
MR Fingerprinting based Quantitative Imaging and Analysis Platform (MRF-QIA) for brain tumors.
$556,813Mark Griswold · Case Western Reserve University · R01 · FY2025 · CA
"Transcranial FUS therapy with closed-loop US image guidance and circulating tumor DNA
$556,557Konstantinos-Costas Arvanitis · Georgia Institute Of Technology · R37 · FY2021 · CA
Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma
$556,541Alfredo Quinones-Hinojosa · Mayo Clinic Jacksonville · R01 · FY2025 · NS
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$556,372Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2022 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$556,372Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2021 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$556,357Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2020 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$556,354Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2019 · CA